Blueprint Medicines seeks a Senior Medical Science Liaison for Northern France including parts of Paris, full time, field based, reporting to the Country Medical Lead. You will be the scientific ambassador, building and maintaining relationships with KOLs, academic centers and healthcare professionals in hematology, pathology, allergy and rare diseases, supporting clinical trials and investigator-initiated studies, delivering scientific trainings, and conveying actionable insights to cross functional teams while staying compliant. Requirements: advanced clinical or science degree (PhD, MD, PharmD, MSc) and 3+ years in biotech or pharma, fluent French and working English, excellent communication and travel readiness. Immunology/oncology/hematology experience and a collaborative ownership mindset are a plus. To apply, tailor your CV to demonstrate KOL engagement, regional strategy, advisory boards, and cross functional impact, and show success in a fast paced, Patients First, Thoughtfulness, Urgency, Trust and Optimism driven environment.
Location(s): Northern France (east to west - including part of Paris)
Level of position: Senior Manager
Position type: Field-based
Reporting Line: This position reports to the Country Medical Lead
How will your role help us transform hope into reality?
The Medical Science Liaison (MSL) is a field-based scientific and clinical expert who strategically supports the medical objectives of Blueprint Medicines’ development programs. As an MSL, you will play a critical role in supporting our mission to improve and extend the lives of patients through precision therapy. You will be responsible for identifying, developing and maintaining strong relationships with key opinion leaders (KOLs) and a network of healthcare professionals, engaging in peer-to-peer conversations and providing scientific and clinical expertise while supporting the commercialization of our products. You will be accountable to understand the external healthcare environment and gaps related to the disease, identify and communicate key actionable insights and fulfill stakeholder information needs in alignment with the overall business strategy.
As the subject-matter expert, you will also support the understanding of key elements of the disease across all different functions within the organization while maintaining full compliance with all relevant international and local requirements. The ideal candidate is expected to be able to navigate a fast-paced environment leveraging the building of strong cross-functional relationships and contributing to execution of strategic priorities.
At Blueprint we place great emphasis on the “How” of our daily job that aligns with our core values and is implemented through the following competencies:
You will also have the opportunity to develop, learn and improve your strategic prioritization attitude and your effect as a potential impact multiplier.
What will you do?
What minimum qualifications do we require?
What additional qualifications will make you a stronger candidate?
Why Blueprint?
At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.
This is the place where the extraordinary becomes reality, and you could be part of it.
Patients are waiting. Are you ready to make the leap?
Blueprint Medicines, a Sanofi company, is a global biopharmaceutical company that seeks to improve and extend patients' lives by solving important medical problems, with a focus on allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a track record of success,leveraging our established research, development, and commercial capability and infrastructure, we aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases and solid tumors. For more information, visit www.BlueprintMedicines.com and follow us on X (formerly Twitter; @BlueprintMeds) and LinkedIn.
*Blueflex is our operating model which optimizes culture, productivity, & flexibility by maximizing the critical strengths of in-person work with the benefits of added flexibility. Blueflex allows for mix of in-office and remote work, enables flexibility to meet individual and business needs and makes effective use of our facilities and resources. It is a culture enhancer.